Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins

A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by b...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23506
Acceso en línea:
https://doi.org/10.1016/j.bbrc.2009.04.138
https://repository.urosario.edu.co/handle/10336/23506
Palabra clave:
HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
Rights
License
Abierto (Texto Completo)
id EDOCUR2_af53e7257cb4e33b49972075216b124b
oai_identifier_str oai:repository.urosario.edu.co:10336/23506
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling d39495d0-c601-4370-a993-42b78fd63e7d-151721018-118e61850-2427-4a1d-aeaf-a88c5dea72e5-1b3ed2fba-3a5b-4e64-9896-4c6cae31683a-19e3ba9df-fe89-48fe-9521-cc8f452d56f5-12020-05-26T00:02:36Z2020-05-26T00:02:36Z2009A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by blocking the parasite's access to hepatic cells, and/or proteins involved in the development of this stage, amongst which are included the Liver Stage Antigen-1 (LSA-1) and the Sporozoite and Liver Stage Antigen (SALSA). Our studies have focused on the search for an association between the structure of high activity binding peptides (HABPs), including both conserved native and their modified analogues, and their ability to bind to the MHC Class II HLA-DR molecules during formation of the MHCII-peptide-TCR complex leading to inducing the appropriate immune response. These studies are part of a logical and rational strategy for developing multi-stage, multi-component, minimal subunit-based vaccines, mainly against the P. falciparum malaria. © 2009 Elsevier Inc. All rights reserved.application/pdfhttps://doi.org/10.1016/j.bbrc.2009.04.1380006291X10902104https://repository.urosario.edu.co/handle/10336/23506eng460No. 4455Biochemical and Biophysical Research CommunicationsVol. 384Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.384, No.4 (2009); pp. 455-460https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649150730&doi=10.1016%2fj.bbrc.2009.04.138&partnerID=40&md5=f675281f5f8f822763200d20c175c9ffAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHLA DR antigenLiver stage antigen 1Major histocompatibility antigen class 2Malaria vaccineParasite antigenPlasmodium falciparum malarial proteinProtozoal proteinSporozoite and liver stage antigenT lymphocyte receptorUnclassified drugAnimal cellAnimal experimentAnimal modelAnimal tissueAntigen structureArticleCell invasionControlled studyHost parasite interactionImmune responseImmunogenicityLiver cellMalariaMonkeyNonhumanNucleotide sequencePlasmodium falciparumPriority journalSporozoiteAmino Acid SequenceAnimalsHLA-DR AntigensImmunizationLiverMalaria VaccinesMolecular Sequence DataPlasmodium falciparumProtozoan ProteinsPlasmodium falciparumHLA-dr?1* moleculesLSA-1MalariaMHCII-peptide-TCR complexSALSASubunitProtozoanSecondaryAntigensProtein StructureVaccinesStructural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteinsarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cifuentes, GladysVanegas, MagnoliaMartinez, Nora LorenaPirajan, CamiloPatarroyo, Manuel ElkinORIGINALStructural_characteristics_of_immunogeni.pdfapplication/pdf3220121https://repository.urosario.edu.co/bitstreams/40f8fd78-06f1-400a-bcab-4127ed89c4f7/download54d41f854a7d2d32829280ec220f30c7MD51TEXTStructural_characteristics_of_immunogeni.pdf.txtStructural_characteristics_of_immunogeni.pdf.txtExtracted texttext/plain31673https://repository.urosario.edu.co/bitstreams/43c18b5e-5379-4831-b6f1-5cdfa9049c6d/download1a97e73d416c5e9dc602bce1fc8cafcfMD52THUMBNAILStructural_characteristics_of_immunogeni.pdf.jpgStructural_characteristics_of_immunogeni.pdf.jpgGenerated Thumbnailimage/jpeg4966https://repository.urosario.edu.co/bitstreams/f5807c92-8846-4c43-babf-94e0fd4f11dd/download014a1d9b17608b027e725c4e3f02b365MD5310336/23506oai:repository.urosario.edu.co:10336/235062022-05-02 07:37:21.027854https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
title Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
spellingShingle Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
title_short Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
title_full Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
title_fullStr Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
title_full_unstemmed Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
title_sort Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins
dc.subject.keyword.spa.fl_str_mv HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
topic HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
dc.subject.keyword.eng.fl_str_mv Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
description A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by blocking the parasite's access to hepatic cells, and/or proteins involved in the development of this stage, amongst which are included the Liver Stage Antigen-1 (LSA-1) and the Sporozoite and Liver Stage Antigen (SALSA). Our studies have focused on the search for an association between the structure of high activity binding peptides (HABPs), including both conserved native and their modified analogues, and their ability to bind to the MHC Class II HLA-DR molecules during formation of the MHCII-peptide-TCR complex leading to inducing the appropriate immune response. These studies are part of a logical and rational strategy for developing multi-stage, multi-component, minimal subunit-based vaccines, mainly against the P. falciparum malaria. © 2009 Elsevier Inc. All rights reserved.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:02:36Z
dc.date.available.none.fl_str_mv 2020-05-26T00:02:36Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.bbrc.2009.04.138
dc.identifier.issn.none.fl_str_mv 0006291X
10902104
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23506
url https://doi.org/10.1016/j.bbrc.2009.04.138
https://repository.urosario.edu.co/handle/10336/23506
identifier_str_mv 0006291X
10902104
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 460
dc.relation.citationIssue.none.fl_str_mv No. 4
dc.relation.citationStartPage.none.fl_str_mv 455
dc.relation.citationTitle.none.fl_str_mv Biochemical and Biophysical Research Communications
dc.relation.citationVolume.none.fl_str_mv Vol. 384
dc.relation.ispartof.spa.fl_str_mv Biochemical and Biophysical Research Communications, ISSN:0006291X, 10902104, Vol.384, No.4 (2009); pp. 455-460
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649150730&doi=10.1016%2fj.bbrc.2009.04.138&partnerID=40&md5=f675281f5f8f822763200d20c175c9ff
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/40f8fd78-06f1-400a-bcab-4127ed89c4f7/download
https://repository.urosario.edu.co/bitstreams/43c18b5e-5379-4831-b6f1-5cdfa9049c6d/download
https://repository.urosario.edu.co/bitstreams/f5807c92-8846-4c43-babf-94e0fd4f11dd/download
bitstream.checksum.fl_str_mv 54d41f854a7d2d32829280ec220f30c7
1a97e73d416c5e9dc602bce1fc8cafcf
014a1d9b17608b027e725c4e3f02b365
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1831928153066438656